GlassScriptPhysician profile
Adam A Sternak
NPI 1437437381
$3,164.41
in general payments reported to CMS, 2019-2025
12 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $408 · 2024: $1,036 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027 · Travel and Lodging: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.51 |
| Travel and Lodging | $530.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $1,200.00 | 2021 | |
| Fusion Orthopedics USA, LLC | $559.67 | 2024 | |
| Stryker Corporation | $407.75 | 2022 | |
| Orthofix Medical, INC. | $200.60 | 2024-2025 | Physio-Stim, Accelstim |
| Exactech, INC. | $171.11 | 2024 | |
| Curonix LLC | $163.08 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $147.44 | 2025 | Wavewriter Alpha Prime 16 |
| Alafair Biosciences, INC. | $94.96 | 2024 | Versawrap |
| Paratek Pharmaceuticals, INC. | $83.78 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $63.72 | 2024-2025 | Collagenase Santyl, Renasys Touch |
| Kuros Biosciences USA, INC | $36.84 | 2025 | Magnetos |
| Paragon 28, INC. | $35.46 | 2024-2025 | Hammertube Sterile Implant Kits, Mtp |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Sternak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.